"It passes through our bodies, our cells and every living organism on the planet, yet we know surprisingly little about ...
Neurodegenerative diseases slowly damage the brain and nervous system, affecting millions of people worldwide. Two of the most common conditions are Alzheimer’s disease (AD) and Parkinson’s disease ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Tiny, metallic, flower-shaped nanoparticles may offer fresh hope for ...
Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people worldwide. Published in the Journal of Neuroscience, new research from the ...
Alzheimer's-related brain changes progressed up to 20 times faster in women who also had abnormal levels of a Parkinson's-related protein, according to a Mayo Clinic study published in JAMA Network ...
Researchers in Japan discovered that Parkinson’s patients diagnosed in their 80s are far more likely to show signs of amyloid buildup, a hallmark of Alzheimer’s, even without dementia symptoms. The ...
Despite their differences, Alzheimer’s disease and Parkinson’s disease share several risk factors and mechanisms of neuronal damage. Both also feature a phase that precedes the appearance of symptoms ...
Tear fluid contains several markers of diseases, such as Parkinson’s disease, Alzheimer’s disease, diabetes, and cancer.
In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain cells. The process of proteins spontaneously clumping is called ...
Researchers at the Laboratory of Psychiatry and Experimental Alzheimer’s Research, Department of Psychiatry and Psychotherapy, Medical University of Innsbruck, have developed a low-cost and ...
Despite growing recognition of the importance of the peripheral immune system in neurodegenerative disease, little is known about how these blood cells change in Alzheimer’s and Parkinson’s diseases.